David Dolby is a San Francisco-based investor and philanthropist focused on science, technology, and media. Mr. Dolby is committed to honoring Ray Dolby’s values and belief in supporting highly innovative cultures with an emphasis on differentiated signal processing to solve real-world problems. Mr. Dolby is CEO of Dolby Family Ventures where he specializes in accelerating the path to a cure for Alzheimer’s disease and seed stage technology investments Mr. Dolby manages a portfolio of over 40 venture investments across aerospace, security and cryptography, computer vision, advanced display technologies, robotics and automation, Alzheimer’s therapeutics, depression therapeutics, neurostimulation, neuroscience imaging, cognition assessment, and independent film impact investments. Mr. Dolby is director of Dolby Laboratories, director of Cogstate Limited, CFO of the Ray and Dagmar Dolby Family Fund, trustee of the Salk Institute for Biological Studies, board member of Tipping Point Community, and trustee of the Academy Museum of Motion Pictures.